non specific binding of antibodies in immunoassays

34
© Innova Biosciences ltd. 2012. All rights reserved © Innova Biosciences ltd. 2012. All rights reserved Quality – Consistency - Expertise

Upload: innova-biosciences

Post on 24-May-2015

427 views

Category:

Science


0 download

DESCRIPTION

Find out more about non-specific binding here: http://www.innovabiosciences.com/innova/non-specific-binding.html How to Overcome all of your Problems with Secondary Antibodies The latest Innova Biosciences webinar focuses on how to overcome the problems of using secondary antibodies. For instance, the use of secondary antibodies: • Requires a series of incubations and wash steps that are both tedious and time consuming. It is amazing how many times people state how much they hate those wash steps! • Can often be a source of non-specific staining within experiments which make data interpretation difficult or even impossible. • Multi-colour analysis often results in cross species re-activity. Secondary antibodies are generally used either because there are no directly labeled primary antibodies or to increase sensitivity. In this seminar, we will review: • How labeling of your own antibodies overcomes the need for secondary antibodies. • How easy it really is to label an antibody using Innova's 30 seconds hands-on antibody labeling kits and design your own unique research tools. • Application data such as flow cytometry and western blotting generated using directly labeled antibodies • And question the hypothesis of secondary vs. primary labeled antibodies.

TRANSCRIPT

Page 1: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved © Innova Biosciences ltd. 2012. All rights reserved

Quality – Consistency - Expertise

Page 2: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Welcome to our third webinar

How to Overcome all your Problems with Secondary Antibodies

Dr Andy Lane

Page 3: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Dr Andy Lane

• Immunoassay fundamentals

• Properties of secondary antibodies

• Direct labelling of primary antibodies

Dr Lane has recently joined Innova Biosciences, where he is well positioned to utilise his antibody conjugation and flow cytometry experience in combination with Innova’s ground-breaking rapid conjugation technology.

Page 4: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Immunoassay fundamentals

1. Antibody specific for target antigen

DIRECT

SANDWICH

Page 5: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Immunoassay fundamentals

1. Antibody specific for target antigen 2. Suitable visualisation method – e.g. enzyme, fluorescent dye, nanoparticle

DIRECT

SANDWICH

Page 6: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Immunoassay fundamentals

In many cases these reagents are not available

DIRECT

SANDWICH

X

X

Page 7: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Immunoassay fundamentals

A common way to deal with this is to use a “secondary antibody” in an “indirect” assay

Page 8: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Properties of secondary antibodies

Anti-species immunoglobulin reagents

Single reagent may be used in many assays

Binding of multiple antibodies may increase signal

Page 9: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Properties of secondary antibodies

BUT……….

Level of non-specific binding in the assay is increased, especially in assays where immunoglobulins from different species are present

Multi-parameter assays are very difficult to run

Increase in sensitivity may not be realised

Assay times are increased due to the additional washes and incubation steps

Page 10: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Increase in non-specific binding

Page 11: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Increase in non-specific binding

especially in systems where immunoglobulins from different species are present

Page 12: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Properties of secondary antibodies

BUT……….

Level of non-specific binding in the assay is increased, especially in assays where immunoglobulins from different species are present

Multi-parameter assays are very difficult to run

Increase in sensitivity may not be realised

Assay times are increased due to the additional washes and incubation steps

Page 13: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Multi-parameter assays are very difficult to run

Page 14: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Multi-parameter assays are very difficult to run

Page 15: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Species cross-reactivity may be reduced by the use of antibodies that have been adsorbed against species immunoglobulin. However, as the most cross-reactive antibodies are those with highest affinity, this results in a reduction in antibody affinity and therefore performance of the antibody. Cross-reactivity may also be due to other factors such as binding to Fc receptors and general low-level non-specific interactions, which increase simply with the amount of antibody present and is not saturable.

Secondary antibody cross-reactivity

Page 16: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Properties of secondary antibodies

BUT……….

Level of non-specific binding in the assay is increased, especially in assays where immunoglobulins from different species are present

Multi-parameter assays are very difficult to run

Increase in sensitivity may not be realised

Assay times are increased due to the additional washes and incubation steps

Page 17: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

All of these problems with secondary antibodies can be overcome by the use of directly conjugated primary antibodies

Page 18: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

No non-specific binding

Page 19: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

No non-specific binding

even in systems where immunoglobulins from different species are present

Page 20: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Multi-parameter assays are straightforward to run

Page 21: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

The major problem with using directly conjugated antibodies in assays is their lack of availability, and also the difficulty of conjugating antibodies yourself by traditional methods.

Page 22: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Features of Lightning-Link®

• Lightning-Link ® - the world’s easiest antibody labeling kits

• Simple, one step process

• Only 30 seconds hands-on

• Reproducible

• Scalable µg to mg

• 100% recovery

Just add primary antibody !

22

Page 23: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved 23

Page 24: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Lightning-Link®

Page 25: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Lightning-Link® Rapid

Lightning-Link® is a registered trademark of Innova Biosciences DyLight® is a registered trademark of Thermo Fisher Scientific Inc. and its subsidiaries

Page 26: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Conjugation considerations

Antibody doesn’t meet these criteria?

You need to know some things about your antibody. Lightning-Link conjugations are really simple but you need antibody in the right format to work effectively. Commercially available antibodies come in many forms, and you may need to check with the supplier about some details.

Concentration – 1mg/ml or higher is preferred

Purity – ensure other proteins have been removed, and also make sure they haven’t been put back again afterwards!

Buffer formulation – most common formulations are suitable, but ensure that amines such as glycine are truly absent, as well as thiols such as DTT or mercaptoethanol. Tris is OK up to 20mM

Use a purification kit to purify, concentrate and/or change the buffer of your antibody

Page 27: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved 27

Page 28: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Using your new conjugates

• Use exactly as normal in terms of staining technique

• Titrate – possibly extensively!

• Storage – at 40C in concentrated form is always best.

• A preservative (e.g. 0.05% w/v sodium azide) may be useful, and if stored diluted a carrier protein would be advised (e.g. 1% w/v BSA)

• Some conjugates may be safely frozen, but others should not be. Never freeze RPE, APC or their tandem forms!

• Keep conjugates away from light – tandem dyes are especially sensitive

28

Page 29: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Directly Labeled Antibodies Indirectly Labeled Antibodies

primary antibody Goat Anti-NQO1 Goat Anti-NQO1

target quinone reductase 1 quinone reductase 1

sample lysate human kidney human kidney

primary antibody working concentration 0.00425 µg/ml 0.1 µg/ml

secondary antibody used no (direct conjugation) yes

exposure time (min) 10 10

primary antibody source Everest Biotech, Cat no: EB05370

western blot analysis

Western blotting data comparing conjugated and unconjugated antibodies (direct and indirect detection)

Page 30: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

conjugated unconjugated

primary antibody Goat Anti-GFAP Goat Anti-GFAP

target GFAP GFAP

sample lysate mouse brain mouse brain

primary antibody working concentration 0.185 µg/ml 0.5 µg/ml

secondary antibody used no (direct conjugation) yes

exposure time (min) 3 3

primary antibody source Everest Biotech, Cat no: EB07478

western blot analysis

Western blotting data comparing conjugated and unconjugated antibodies (direct and indirect detection)

Page 31: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved © Innova Biosciences ltd. 2012. All rights reserved

Please visit our booth

ASCB annual meeting Booth 442

Page 32: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Page 33: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Contact

If you would like any more information, please contact us at [email protected]

Please keep an eye out for our future webinars and other exciting news on our website and social media channels:

www.innovabiosciences.com/innova/webinars.html

YouTube: www.youtube.com/InnovaBiosciences

Page 34: Non Specific Binding of Antibodies in Immunoassays

© Innova Biosciences ltd. 2012. All rights reserved

Innova Biosciences Ltd.

Babraham Research Campus,

Cambridge, UK,

CB22 3AT

www.innovabiosciences.com

Lightning-Link® is a registered trademark of Innova Biosciences DyLight® is a registered trademark of Thermo Fisher Scientific Inc. and its subsidiaries